Antiperistaltic Antidiarrheal Drugs has 5 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Methenamine, Sodium Phosphate, Monobasic, Methylene Blue, And Hyoscyamine Sulfate, Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, And Hyoscyamine Sulfate, Metoclopramide. Patients taking Antiperistaltic Antidiarrheal Drugs should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 5
- Moderate
- 5
Moderate (5)
- Antiperistaltic Antidiarrheal Drugs + Methenamine, Sodium Phosphate, Monobasic, Methylene Blue, And Hyoscyamine Sulfate— May reduce absorption of hyoscyamine due to effects on GI motility. Doses should be spaced 1 hour apart.
- Antiperistaltic Antidiarrheal Drugs + Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, And Hyoscyamine Sulfate— May reduce absorption of hyoscyamine resulting in decreased therapeutic effectiveness. Doses should be spaced 1 hour apa…
- Antiperistaltic Antidiarrheal Drugs + Metoclopramide— Impair GI motility and decrease metoclopramide systemic absorption. Monitor for reduced therapeutic effect.
- Antiperistaltic Antidiarrheal Drugs + Metoclopramide Hydrochloride— Potential for decreased metoclopramide effect due to opposing effects on gastrointestinal motility. Monitor for reduced …
- Antiperistaltic Antidiarrheal Drugs + Urinary Antiseptic Antispasmodic— May reduce absorption of hyoscyamine due to effects on gastrointestinal motility. Space doses 1 hour apart.